{"name":"Molecular Data","slug":"molecular-data","ticker":"MKD","exchange":"NASDAQ","domain":"molbase.com","description":"Molecular Data is a chemical e-commerce and life sciences supply chain company. They focus on providing innovative solutions for the pharmaceutical industry. Their top products include a range of chemicals and materials used in the development of various drugs. As a leader in the industry, Molecular Data has established itself as a trusted partner for pharmaceutical companies.","hq":"Shanghai, China","founded":2019,"employees":"~75,000","ceo":"Xiaoyu Shao","sector":"Chemical E-Commerce / Life Sciences Supply Chain","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"123.4B","metrics":{"revenue":500000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Drug X patent cliff ($100M at risk)","drug":"Drug X","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Molecular Data Reports Q4 2023 Earnings","summary":"Molecular Data reported its Q4 2023 earnings, with revenue increasing by 15% year-over-year.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"Molecular Data Partners with Leading Pharmaceutical Company","summary":"Molecular Data announced a partnership with a leading pharmaceutical company to provide supply chain solutions.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9SbGtmZmltTm43OTlGbFl4VDdibEJiY1NBYjVVeTdfc1pRMm1aczl1c1ZKWlozQ0tYOUpxbC1TcEVwQzJZWnFSdWN4NDlBT2t5RDFSdDZISWV4b3g4a2dXMFMxNGNyZW5kel9UalVEbTNpSnVyYXEyUUxBZw?oc=5","date":"2021-09-02","type":"pipeline","source":"Yahoo Finance","summary":"10 Top Penny Stocks To Watch After ANY Stock’s 559% Short Squeeze - Yahoo Finance","headline":"10 Top Penny Stocks To Watch After ANY Stock’s 559% Short Squeeze","sentiment":"neutral"}],"patents":[{"drugName":"Drug X","drugSlug":"generic-x","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Company A","Company B","Company C"],"therapeuticFocus":["Oncology","Cardiovascular"],"financials":null,"yahoo":null}